Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
17 April 2024, Israel: Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), today
Read More